Drug copies ready to take next bite out of Roche’s cancer sales

Print pagePDF pageEmail page

LONDON (Reuters) – European oncologists will soon get their hands on cut-price copies of breast cancer drug Herceptin, turning the screws on maker Roche and giving another boost to a new breed of companies focused on so-called biosimilars.


Reuters: Health News … More ادامه مطلب

Leave a Reply

Time limit is exhausted. Please reload CAPTCHA.

Positive SSL